Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-11

Clinical Trial Update: A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004542) [Phase 2]

View source ↗

Summary

A Phase 2 trial by Aderans Research Institute evaluated autologous dermal sheath cup cell injections for androgenetic alopecia and related pattern baldness; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Autologous dermal sheath cup cells (dermal sheath cup (DSC) cells)

Snippet

Sponsor: Aderans Research Institute | Conditions: Androgenetic Alopecia, Male Pattern Baldness | Phase 2 | Status: COMPLETED